期刊文献+

男性脱发与前列腺癌发病风险的相关性:一项系统回顾和荟萃分析

Male pattern baldness and risk of prostate cancer:a systematic review and meta-analysis
原文传递
导出
摘要 目的:通过开展基于既往相关队列研究和病例对照研究的荟萃分析,研究男性脱发与前列腺癌发病风险的相关性。方法:文献检索自PubMed、Web of Science和中国知网数据库,检索截止时间为2017年5月30日。DerSimonian-Laird随机效应模型被用于计算合并后的RR和95%CI。结果:本项荟萃分析共纳入15项研究。在总体分析中,男性脱发(任何类型)与前列腺癌发病风险之间无相关性(RR=1.03,95%CI:0.96~1.11)。纳入研究之间存在显著的异质性(P=0.078,I^2=36.4%)。对脱发类型进行亚组分析,发现头顶脱发和前列腺癌发病风险显著相关(RR=1.24,95%CI:1.05~1.46),而其他类型的脱发则无相关性。结论:头顶脱发的男性可能具有较高的前列腺癌发病风险,但由于总体分析以及大多数的亚组分析结果阴性,并且研究之间存在一定的异质性,本研究结果还需进一步设计良好的前瞻性队列研究来验证。 Objective:The relationship between male pattern baldness and incidence of prostate cancer is still inconclusive.Hence we performed the present meta-analysis based on eligible relevant cohort and case-control studies.Method:A comprehensive literature search was performed in May 2017 based on PubMed,Web and CNKI of Science databases.Pooled RR and its 95% CI was calculated with a DerSimonian and Laird randomeffects model.Result:Finally,a total of 15 studies were included in this meta-analysis.Overall,no statistically significant association between baldness(any pattern)and prostate cancer risk was identified(RR=1.03,95%CI:0.96-1.11).There was obvious heterogeneity across included studies(P=0.078 for heterogeneity,I^2=36.4%).When subgroup analysis by types of baldness,statistically significant association was observed for vertex baldness(RR=1.24,95%CI:1.05-1.46)but not for other types of baldness.Conclusion:Individuals with vertex baldness may have an increased risk of prostate cancer.Given the obvious heterogeneity and null results in overall analysis and most of subgroup analyses,further large well-designed prospective cohort studies are warranted to confirm our preliminary findings.
作者 章冠军 章雪峰 许雄杰 ZHANG Guanjun;ZHANG Xuefeng;XU Xiongjie(Department of Urology,Hospital of Traditional Chinese Medicine of Shangyu,Shaoxin,Zhejiang,312300,China)
出处 《临床泌尿外科杂志》 2018年第12期976-980,984,共6页 Journal of Clinical Urology
关键词 男性脱发 前列腺癌 荟萃分析 风险 male pattern baldness prostate cancer meta-analysis risk
  • 相关文献

参考文献2

二级参考文献37

  • 1Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014 [J]. CACancerJ Clin, 2014, 64(1): 9-29.
  • 2Center M M, Jemal A, Lortet-Tieulent J, et al. Inter- national variation in prostate cancer incidence and mor- tality rates[J]. Eur Urol, 2012, 61(6): 1079-1092.
  • 3Puccetti L, Supuran C T, Fasolo P P, et al. Skewing towards neuroendocrine phenotype in high grade or high stage androgen-responsive primary prostate cancer [J]. Eur Urol, 2005, 48(2): 215-221; discussion221-223.
  • 4Sun Y, Niu J, Huang J. Neuroendocrine differentiation in prostate cancer[J]. Am J Transl Res, 2009, 1(2) : 148-162.
  • 5Vashchenko N, Ahrahamsson P A. Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities[J]. Eur Urol, 2005, 47(2): 147 -155.
  • 6Yuan T C, Veeramani S, Lin M F. Neuroendocrine- like prostate cancer cells: neuroendocrine transdifferen- tiation of prostate adenocarcinoma cells[J]. Endocr Re- lat Cancer, 2007, 14(3): 531-547.
  • 7Beltran H, Tomlins S, Aparicio A, etal. Aggressive variants of castration-resistant prostate cancer[J]. Clin Cancer Res, 2014, 20(11): 2846-2850.
  • 8QuirSs I, Sdinz R M, Hevia 15, et al. Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells[J]. Int J Cancer, 2009, 125(7): 1497- 1504.
  • 9Lin D, Wyatt A W, Xue H, et al. High fidelity pa- tient-derived xenografts for accelerating prostate cancer discovery and drug development [ [J]. Cancer Res, 2014, 74(4): 1272-1283.
  • 10Marchiani S, Tamburrino L, Nesi G, et al. Androgen- responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation[J]. Int J Androl, 2010, 33(6): 784- 793.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部